Assembly Biosciences(us:ASMB)
15.21
-3.80%
Updated on 2024-12-22
Open:15.70
Close:15.21
High:16.26
Low:15.00
Pre Close:15.81
Volume:30655.00
Amount:478060.19
Turnover:0.48%
Shares:6.36M
MarketCap:96.68M
About Assembly Biosciences Company
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
Company Name: Assembly Biosciences
Company Address: Two Tower Place,7th floor
Employees: 65
Fiscar Year: 12-31
IPO Date: 2010-12-17
Website: http://www.assemblybio.com
CIK: 1426800
View all SEC Filings
About
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
Address:Two Tower Place,7th floor
Website:http://www.assemblybio.com
Market Movers